The big picture: University of Utah spinout Epitel has closed a $26 million Series B financing round to expand access to its wireless, AI-assisted electroencephalography technology.
The round was co-led by Catalyst Health Ventures and Genoa Ventures, with participation from new and existing investors. Epitel will use the funding to grow its commercial team, accelerate provider adoption and expand deployment of its REMI Remote EEG Monitoring System. Business Wire
Born at the U: Epitel was founded by Mark Lehmkuhle while he was a research assistant professor in the University of Utah Department of Neurosurgery. The Salt Lake City-based company grew from U research focused on making brain monitoring more practical and accessible.
How it works: Epitel’s REMI platform uses small, wearable sensors to record brain activity without tethering patients to conventional EEG equipment. Its AI-assisted software can flag potential seizure events for clinician review, while the wireless system allows monitoring to continue at home and during everyday activities for days or weeks. The technology has received five FDA 510(k) clearances and can be used for neurological monitoring in patients as young as one year old. Business Wire
Why it matters for patients
Seizures can be rare, unpredictable and difficult to capture during a traditional EEG appointment. Epitel says 40% of the 9.2 million Americans who experience seizures each year lack access to EEG, while many hospitals do not have EEG capabilities. Business Wire
Longer-term monitoring could give clinicians more opportunities to capture objective evidence of seizure activity—without requiring patients to remain in a hospital or navigate cumbersome wired equipment. For patients and families, that could mean a more comfortable monitoring experience, faster answers and broader access to neurological care, particularly outside major medical centers.
What’s next: Epitel plans to expand its sales, marketing and customer-experience teams while helping more health systems incorporate REMI into clinical workflows. The new capital positions the company to bring a U-developed innovation to more providers—and potentially more patients—across the country.
Read the full funding announcement.
Interested in launching a startup based on U of U Research? Explore the faculty startup guide →
